The Influence of Clinically Diagnosed Neuropathy on Respiratory Muscle Strength in Type 2 Diabetes Mellitus

Objectives. This cross-sectional study investigated the influence of clinically diagnosed neuropathy (cdNP) on respiratory muscle strength in patients with type 2 diabetes mellitus (T2DM). Methods. 110 T2DM patients and 35 nondiabetic healthy controls (≥60 years) were allocated to one of three group...

Full description

Saved in:
Bibliographic Details
Main Authors: Birgit L. M. Van Eetvelde, Dirk Cambier, Karsten Vanden Wyngaert, Bert Celie, Patrick Calders
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2018/8065938
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560940611010560
author Birgit L. M. Van Eetvelde
Dirk Cambier
Karsten Vanden Wyngaert
Bert Celie
Patrick Calders
author_facet Birgit L. M. Van Eetvelde
Dirk Cambier
Karsten Vanden Wyngaert
Bert Celie
Patrick Calders
author_sort Birgit L. M. Van Eetvelde
collection DOAJ
description Objectives. This cross-sectional study investigated the influence of clinically diagnosed neuropathy (cdNP) on respiratory muscle strength in patients with type 2 diabetes mellitus (T2DM). Methods. 110 T2DM patients and 35 nondiabetic healthy controls (≥60 years) were allocated to one of three groups depending on the presence of cdNP: T2DM without cdNP (D−; n=28), T2DM with cdNP (D+; n=82), and controls without cdNP (C; n=35). Clinical neurological diagnostic examination consisted of Vibration Perception Threshold and Diabetic Neuropathy Symptom score. Respiratory muscle strength was registered by maximal Inspiratory and Expiratory Pressures (PImax and PEmax), and respiratory function by Peak Expiratory Flow (PEF). Isometric Handgrip Strength and Short Physical Performance Battery were used to evaluate peripheral skeletal muscle strength and physical performance. Univariate analysis of covariance was used with age, level of physical activity, and body mass index as covariates. Results. PImax, PEmax, and PEF were higher in C compared to D− and D+. Exploring more in detail, PImax, PEmax, and PEF were significantly lower in D+ compared to C. PEmax and PEF were also significantly lower in D− versus C. Measures of peripheral muscle strength and physical performance showed less associations with cdNP and T2DM. Conclusions. The presence of cdNP affects respiratory muscle strength in T2DM patients compared to healthy controls. Both cdNP and diabetes in themselves showed a distinctive impact on respiratory muscle strength and function; however, an accumulating effect could not be ascertained in this study. As commonly used measures of peripheral muscle strength and physical performance seemed to be less affected at the given time, the integration of PImax, PEmax, and PEF measurements in the assessment of respiratory muscle weakness could be of added value in the (early) screening for neuropathy in patients with T2DM.
format Article
id doaj-art-486068d1185f41cbbef487fa6843dfed
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-486068d1185f41cbbef487fa6843dfed2025-02-03T01:26:16ZengWileyJournal of Diabetes Research2314-67452314-67532018-01-01201810.1155/2018/80659388065938The Influence of Clinically Diagnosed Neuropathy on Respiratory Muscle Strength in Type 2 Diabetes MellitusBirgit L. M. Van Eetvelde0Dirk Cambier1Karsten Vanden Wyngaert2Bert Celie3Patrick Calders4Department of Rehabilitation Sciences and Physiotherapy, Ghent University, Ghent, BelgiumDepartment of Rehabilitation Sciences and Physiotherapy, Ghent University, Ghent, BelgiumDepartment of Rehabilitation Sciences and Physiotherapy, Ghent University, Ghent, BelgiumDepartment of Rehabilitation Sciences and Physiotherapy, Ghent University, Ghent, BelgiumDepartment of Rehabilitation Sciences and Physiotherapy, Ghent University, Ghent, BelgiumObjectives. This cross-sectional study investigated the influence of clinically diagnosed neuropathy (cdNP) on respiratory muscle strength in patients with type 2 diabetes mellitus (T2DM). Methods. 110 T2DM patients and 35 nondiabetic healthy controls (≥60 years) were allocated to one of three groups depending on the presence of cdNP: T2DM without cdNP (D−; n=28), T2DM with cdNP (D+; n=82), and controls without cdNP (C; n=35). Clinical neurological diagnostic examination consisted of Vibration Perception Threshold and Diabetic Neuropathy Symptom score. Respiratory muscle strength was registered by maximal Inspiratory and Expiratory Pressures (PImax and PEmax), and respiratory function by Peak Expiratory Flow (PEF). Isometric Handgrip Strength and Short Physical Performance Battery were used to evaluate peripheral skeletal muscle strength and physical performance. Univariate analysis of covariance was used with age, level of physical activity, and body mass index as covariates. Results. PImax, PEmax, and PEF were higher in C compared to D− and D+. Exploring more in detail, PImax, PEmax, and PEF were significantly lower in D+ compared to C. PEmax and PEF were also significantly lower in D− versus C. Measures of peripheral muscle strength and physical performance showed less associations with cdNP and T2DM. Conclusions. The presence of cdNP affects respiratory muscle strength in T2DM patients compared to healthy controls. Both cdNP and diabetes in themselves showed a distinctive impact on respiratory muscle strength and function; however, an accumulating effect could not be ascertained in this study. As commonly used measures of peripheral muscle strength and physical performance seemed to be less affected at the given time, the integration of PImax, PEmax, and PEF measurements in the assessment of respiratory muscle weakness could be of added value in the (early) screening for neuropathy in patients with T2DM.http://dx.doi.org/10.1155/2018/8065938
spellingShingle Birgit L. M. Van Eetvelde
Dirk Cambier
Karsten Vanden Wyngaert
Bert Celie
Patrick Calders
The Influence of Clinically Diagnosed Neuropathy on Respiratory Muscle Strength in Type 2 Diabetes Mellitus
Journal of Diabetes Research
title The Influence of Clinically Diagnosed Neuropathy on Respiratory Muscle Strength in Type 2 Diabetes Mellitus
title_full The Influence of Clinically Diagnosed Neuropathy on Respiratory Muscle Strength in Type 2 Diabetes Mellitus
title_fullStr The Influence of Clinically Diagnosed Neuropathy on Respiratory Muscle Strength in Type 2 Diabetes Mellitus
title_full_unstemmed The Influence of Clinically Diagnosed Neuropathy on Respiratory Muscle Strength in Type 2 Diabetes Mellitus
title_short The Influence of Clinically Diagnosed Neuropathy on Respiratory Muscle Strength in Type 2 Diabetes Mellitus
title_sort influence of clinically diagnosed neuropathy on respiratory muscle strength in type 2 diabetes mellitus
url http://dx.doi.org/10.1155/2018/8065938
work_keys_str_mv AT birgitlmvaneetvelde theinfluenceofclinicallydiagnosedneuropathyonrespiratorymusclestrengthintype2diabetesmellitus
AT dirkcambier theinfluenceofclinicallydiagnosedneuropathyonrespiratorymusclestrengthintype2diabetesmellitus
AT karstenvandenwyngaert theinfluenceofclinicallydiagnosedneuropathyonrespiratorymusclestrengthintype2diabetesmellitus
AT bertcelie theinfluenceofclinicallydiagnosedneuropathyonrespiratorymusclestrengthintype2diabetesmellitus
AT patrickcalders theinfluenceofclinicallydiagnosedneuropathyonrespiratorymusclestrengthintype2diabetesmellitus
AT birgitlmvaneetvelde influenceofclinicallydiagnosedneuropathyonrespiratorymusclestrengthintype2diabetesmellitus
AT dirkcambier influenceofclinicallydiagnosedneuropathyonrespiratorymusclestrengthintype2diabetesmellitus
AT karstenvandenwyngaert influenceofclinicallydiagnosedneuropathyonrespiratorymusclestrengthintype2diabetesmellitus
AT bertcelie influenceofclinicallydiagnosedneuropathyonrespiratorymusclestrengthintype2diabetesmellitus
AT patrickcalders influenceofclinicallydiagnosedneuropathyonrespiratorymusclestrengthintype2diabetesmellitus